Arrowhead Pharmaceuticals Statistics
Total Valuation
ARWR has a market cap or net worth of $1.76 billion. The enterprise value is $2.20 billion.
Important Dates
The last earnings date was Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ARWR has 126.10 million shares outstanding. The number of shares has increased by 15.92% in one year.
| Current Share Class | 126.10M |
| Shares Outstanding | 126.10M |
| Shares Change (YoY) | +15.92% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 4.79% |
| Owned by Institutions (%) | 74.75% |
| Float | 108.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.23 |
| Forward PS | 6.79 |
| PB Ratio | 33.36 |
| P/TBV Ratio | 2.58 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.04 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.71, with a Debt / Equity ratio of 0.92.
| Current Ratio | 0.71 |
| Quick Ratio | 0.71 |
| Debt / Equity | 0.92 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.86 |
Financial Efficiency
Return on equity (ROE) is -26.22% and return on invested capital (ROIC) is -6.72%.
| Return on Equity (ROE) | -26.22% |
| Return on Assets (ROA) | -5.86% |
| Return on Invested Capital (ROIC) | -6.72% |
| Return on Capital Employed (ROCE) | -9.05% |
| Revenue Per Employee | $895,253 |
| Profits Per Employee | -$236,402 |
| Employee Count | 609 |
| Asset Turnover | 0.43 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ARWR has paid $2.40 million in taxes.
| Income Tax | 2.40M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.73% in the last 52 weeks. The beta is 0.90, so ARWR's price volatility has been similar to the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | -36.73% |
| 50-Day Moving Average | 13.76 |
| 200-Day Moving Average | 19.35 |
| Relative Strength Index (RSI) | 54.82 |
| Average Volume (20 Days) | 1,628,125 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, ARWR had revenue of $545.21 million and -$143.97 million in losses. Loss per share was -$1.13.
| Revenue | 545.21M |
| Gross Profit | 545.21M |
| Operating Income | -118.55M |
| Pretax Income | -539.92M |
| Net Income | -143.97M |
| EBITDA | -98.28M |
| EBIT | -118.55M |
| Loss Per Share | -$1.13 |
Full Income StatementBalance Sheet
The company has $185.71 million in cash and $626.20 million in debt, giving a net cash position of -$440.49 million or -$3.49 per share.
| Cash & Cash Equivalents | 185.71M |
| Total Debt | 626.20M |
| Net Cash | -440.49M |
| Net Cash Per Share | -$3.49 |
| Equity (Book Value) | 684.23M |
| Book Value Per Share | 4.95 |
| Working Capital | -77.36M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | -571.61M |
| FCF Per Share | -$4.53 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -21.74% and -26.41%.
| Gross Margin | 100.00% |
| Operating Margin | -21.74% |
| Pretax Margin | -27.93% |
| Profit Margin | -26.41% |
| EBITDA Margin | -18.03% |
| EBIT Margin | -21.74% |
| FCF Margin | n/a |